184
Participants
Start Date
December 31, 2003
Primary Completion Date
December 31, 2005
Study Completion Date
December 31, 2005
CPG 7909 Injection
CPG 7909 Injection administered subcutaneously at a dose of 40 mg weekly.
dacarbazine
dacarbazine 850mg/m2 in three-week cycles until disease progression
Chemotherapy
"Chemotherapy in three-week cycles until disease progression:~dacarbazine 850mg/m2"
CPG 7909 Injection
CPG 7909 Injection administered subcutaneously at a dose of 10 mg weekly.
CPG 7909 Injection
CPG 7909 Injection administered subcutaneously at a dose of 40 mg weekly.
Lead Sponsor
Pfizer
INDUSTRY